ArticleTranslational lung cancer research2024

Response to platinum-based therapies in second-line after immunotherapy in advanced or metastatic non-small-cell lung cancer PD-L1 ≥50.

Alejandro Olivares-Hernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.